Axon Enterprise, Inc $AXON Stock Sold by Defender Capital LLC.

Defender Capital LLC. reduced its holdings in Axon Enterprise, Inc (NASDAQ:AXON) by 3.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 71,910 shares of the biotechnology company’s stock after selling 2,575 shares during the quarter. Axon Enterprise comprises 9.5% of Defender Capital LLC.’s investment portfolio, making the stock its 4th largest position. Defender Capital LLC.’s holdings in Axon Enterprise were worth $30,383,000 as of its most recent SEC filing.

Several other hedge funds have also recently made changes to their positions in AXON. State Street Corp raised its holdings in shares of Axon Enterprise by 5,700.2% during the second quarter. State Street Corp now owns 213,561,844 shares of the biotechnology company’s stock valued at $119,724,905,000 after acquiring an additional 209,879,882 shares in the last quarter. Envestnet Asset Management Inc. boosted its holdings in Axon Enterprise by 18,050.2% in the second quarter. Envestnet Asset Management Inc. now owns 13,200,075 shares of the biotechnology company’s stock valued at $7,400,094,000 after acquiring an additional 13,127,348 shares in the last quarter. The Manufacturers Life Insurance Company increased its position in Axon Enterprise by 8,432.6% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 3,537,957 shares of the biotechnology company’s stock valued at $1,983,414,000 after purchasing an additional 3,496,493 shares during the period. Nykredit A S bought a new position in Axon Enterprise in the 2nd quarter worth $698,937,000. Finally, QRG Capital Management Inc. raised its holdings in Axon Enterprise by 70,966.0% in the 2nd quarter. QRG Capital Management Inc. now owns 838,579 shares of the biotechnology company’s stock worth $470,116,000 after purchasing an additional 837,399 shares in the last quarter. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey Kunins sold 9,605 shares of the company’s stock in a transaction on Friday, August 21st. The stock was sold at an average price of $626.70, for a total transaction of $6,019,453.50. Following the completion of the sale, the insider owned 97,761 shares in the company, valued at approximately $61,266,818.70. This represents a 8.95% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Patrick Smith sold 10,000 shares of the stock in a transaction dated Tuesday, September 8th. The shares were sold at an average price of $508.99, for a total value of $5,089,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,118,012 shares in the company, valued at approximately $1,587,036,927.88. This represents a 0.32% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders sold 57,397 shares of company stock worth $33,160,884. 4.20% of the stock is currently owned by insiders.

Axon Enterprise Stock Down 0.1%

AXON traded down $0.31 during trading on Thursday, hitting $422.21. 828,891 shares of the company’s stock traded hands, compared to its average volume of 1,053,384. The company’s 50 day simple moving average is $533.23 and its two-hundred day simple moving average is $480.22. The company has a current ratio of 2.15, a quick ratio of 1.80 and a debt-to-equity ratio of 0.47. Axon Enterprise, Inc has a 12-month low of $339.01 and a 12-month high of $764.02. The stock has a market capitalization of $34.30 billion, a price-to-earnings ratio of 175.19, a PEG ratio of 7.90 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON) last issued its earnings results on Wednesday, August 5th. The biotechnology company reported $1.88 earnings per share for the quarter, topping analysts’ consensus estimates of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to analyst estimates of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.Axon Enterprise’s revenue was up 35.3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.12 EPS. Analysts predict that Axon Enterprise, Inc will post 2.12 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently weighed in on AXON. Citizens Jmp reaffirmed a “market outperform” rating and set a $700.00 target price on shares of Axon Enterprise in a research note on Thursday, June 25th. The Goldman Sachs Group restated a “buy” rating and set a $715.00 price target on shares of Axon Enterprise in a research report on Thursday, August 6th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Axon Enterprise in a research note on Wednesday, August 5th. Citigroup reaffirmed a “market outperform” rating on shares of Axon Enterprise in a research report on Thursday, September 17th. Finally, TD Cowen reiterated a “buy” rating on shares of Axon Enterprise in a research note on Wednesday, July 22nd. Fourteen investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $721.57.

About Axon Enterprise

Axon Enterprise, Inc develops technology and connected systems for public safety and law enforcement agencies. Its product portfolio includes TASER conducted energy weapons, body-worn cameras, in-car cameras and other recording devices designed to support safer interactions, improve accountability and document incidents.

The company also provides cloud-based software for managing digital evidence, reports, records and agency operations. Its Axon platform connects hardware with services such as evidence management, real-time operations, computer-aided dispatch and other workflow tools, enabling agencies to store, organize and share information across their organizations.

Founded in 1993 as AIR TASER by Rick Smith and Tom Smith, the company later operated as TASER International before adopting the name Axon Enterprise in 2017.